Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM plus Targeted Therapy in Advanced Pulmonary Adenocarcinoma
NCT02889692Phase 3Completed
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Mar 2013
- Primary completion
- Dec 2016
- Modality
- Traditional Chinese Medicine Formula
01
Overview
A Phase 3 trial of YiQiYangYinFang in pulmonary adenocarcinoma (LUAD), sponsored by Shanghai University of Traditional Chinese Medicine. Started Mar 2013; status: completed.
02
Drugs
YiQiYangYinFang
03
Conditions
pulmonary adenocarcinoma (LUAD)
Beyond the preview
Go deeper on NCT02889692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02889692.